‘QAAMS’ stands for Quality Assurance for Aboriginal and Torres Strait Islander Medical Services.
QAAMS is an Australian Government funded national program that provides a culturally appropriate and clinically effective diabetes management service for Aboriginal and Torres Strait Islander people. It uses on-site point-of-care pathology testing for haemoglobin A1c (HbA1c) and urine albumin:creatinine ratio (ACR) conducted on the Siemens DCA /Vantage under a quality management framework.
The QAAMS Program has proven to be a successful and sustainable project. Established in 1999, operations have progressed and expanded over the past 15 years. For more information go to the QAAMS website.
If you are a QAAMS participant, please go the QAAMS website for information about training, competency assessment, quality management and Medicare rebates. You can also contact our Centre about all QAAMS matters on 08 8201 7555.
Through the research conducted in QAAMS, there is now a sound research evidence base to prove that:
In 2013, the Foundation for the Advancement of International Medical Education and Research (FAIMER) recognised the QAAMS Program for a ‘Projects That Works’ award. QAAMS was one of only five global recipients of this award (from over 120 applications).
This prestigious award recognises projects of greater than three year’s duration which have had a significantly impact on ‘Improving Rural and Community-based Healthcare’.
There are over 190 Aboriginal and Torres Strait Islander medical sites enrolled in the national QAAMS Program. Every State and Territory is represented. This map shows the general location of services in the QAAMS Program.
Kristina Barancek and Lisa Jolly represent the RCPA Quality Assurance Programs Pty Ltd.
Yvette Kruger and Simon Vale represent Siemens Healthcare
David Dunn is the QAAMS Program's Clinical Support Officer.